290 related articles for article (PubMed ID: 27063469)
1. Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.
Dioszeghy V; Mondoulet L; Puteaux E; Dhelft V; Ligouis M; Plaquet C; Dupont C; Benhamou PH
Cell Mol Immunol; 2017 Sep; 14(9):770-782. PubMed ID: 27063469
[TBL] [Abstract][Full Text] [Related]
2. The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.
Dioszeghy V; Mondoulet L; Dhelft V; Ligouis M; Puteaux E; Dupont C; Benhamou PH
Clin Exp Allergy; 2014 Jun; 44(6):867-81. PubMed ID: 24666588
[TBL] [Abstract][Full Text] [Related]
3. Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut-sensitized mice.
Mondoulet L; Dioszeghy V; Busato F; Plaquet C; Dhelft V; Bethune K; Leclere L; Daviaud C; Ligouis M; Sampson H; Dupont C; Tost J
Allergy; 2019 Jan; 74(1):152-164. PubMed ID: 29779209
[TBL] [Abstract][Full Text] [Related]
4. Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.
Dioszeghy V; Mondoulet L; Laoubi L; Dhelft V; Plaquet C; Bouzereau A; Dupont C; Sampson H
Front Immunol; 2018; 9():1951. PubMed ID: 30233572
[TBL] [Abstract][Full Text] [Related]
5. Current Status of Potential Therapies for IgE-Mediated Food Allergy.
Parrish CP; Har D; Andrew Bird J
Curr Allergy Asthma Rep; 2018 Feb; 18(3):18. PubMed ID: 29470658
[TBL] [Abstract][Full Text] [Related]
6. Epicutaneous immunotherapy induces gastrointestinal LAP
Tordesillas L; Mondoulet L; Blazquez AB; Benhamou PH; Sampson HA; Berin MC
J Allergy Clin Immunol; 2017 Jan; 139(1):189-201.e4. PubMed ID: 27417020
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic perspectives in food allergy.
Marcucci F; Isidori C; Argentiero A; Neglia C; Esposito S
J Transl Med; 2020 Aug; 18(1):302. PubMed ID: 32758254
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Food Allergy: Are We There Yet?
Gernez Y; Nowak-Węgrzyn A
J Allergy Clin Immunol Pract; 2017; 5(2):250-272. PubMed ID: 28283151
[TBL] [Abstract][Full Text] [Related]
9. Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice.
Mondoulet L; Dioszeghy V; Larcher T; Ligouis M; Dhelft V; Puteaux E; Cherel Y; Letourneur F; Dupont C; Benhamou PH
PLoS One; 2012; 7(2):e31967. PubMed ID: 22363776
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy approaches for peanut allergy.
Kim EH; Patel C; Burks AW
Expert Rev Clin Immunol; 2020 Feb; 16(2):167-174. PubMed ID: 31928251
[No Abstract] [Full Text] [Related]
11. Update on peanut allergy: Prevention and immunotherapy.
Cook QS; Kim EH
Allergy Asthma Proc; 2019 Jan; 40(1):14-20. PubMed ID: 30582491
[No Abstract] [Full Text] [Related]
12. Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsiveness.
Orgel K; Burk C; Smeekens J; Suber J; Hardy L; Guo R; Burks AW; Kulis M
Clin Exp Allergy; 2019 Apr; 49(4):461-470. PubMed ID: 30383313
[TBL] [Abstract][Full Text] [Related]
13. Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.
Mondoulet L; Dioszeghy V; Puteaux E; Ligouis M; Dhelft V; Plaquet C; Dupont C; Benhamou PH
J Allergy Clin Immunol; 2015 Jun; 135(6):1546-57.e4. PubMed ID: 25583102
[TBL] [Abstract][Full Text] [Related]
14. Oral immunotherapy with omalizumab reverses the Th2 cell-like programme of regulatory T cells and restores their function.
Abdel-Gadir A; Schneider L; Casini A; Charbonnier LM; Little SV; Harrington T; Umetsu DT; Rachid R; Chatila TA
Clin Exp Allergy; 2018 Jul; 48(7):825-836. PubMed ID: 29700872
[TBL] [Abstract][Full Text] [Related]
15. The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy.
Liu G; Liu M; Wang J; Mou Y; Che H
Front Immunol; 2021; 12():660974. PubMed ID: 34305893
[TBL] [Abstract][Full Text] [Related]
16. Food allergy immunotherapy: Oral immunotherapy and epicutaneous immunotherapy.
Kim EH; Burks AW
Allergy; 2020 Jun; 75(6):1337-1346. PubMed ID: 32034781
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of allergen-specific immunotherapy for peanut allergy: a meta-analysis of randomized controlled trials.
Sun J; Hui X; Ying W; Liu D; Wang X
Allergy Asthma Proc; 2014; 35(2):171-7. PubMed ID: 24717795
[TBL] [Abstract][Full Text] [Related]
18. Systemic IL-2/anti-IL-2Ab complex combined with sublingual immunotherapy suppresses experimental food allergy in mice through induction of mucosal regulatory T cells.
Smaldini PL; Trejo F; Cohen JL; Piaggio E; Docena GH
Allergy; 2018 Apr; 73(4):885-895. PubMed ID: 29319881
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow's milk- and peanut allergy models.
Vonk MM; Wagenaar L; Pieters RHH; Knippels LMJ; Willemsen LEM; Smit JJ; van Esch BCAM; Garssen J
Clin Transl Allergy; 2017; 7():35. PubMed ID: 29021893
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) CD25(+) T regulatory cells do not transfer oral tolerance to peanut allergens in a mouse model of peanut allergy.
Marcondes Rezende M; Hassing I; Bol-Schoenmakers M; Bleumink R; Boon L; van Bilsen J; Pieters R
Clin Exp Allergy; 2011 Sep; 41(9):1324-33. PubMed ID: 21338425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
